Logo image of FONR

FONAR CORP (FONR) Stock Fundamental Analysis

USA - NASDAQ:FONR - US3444374058 - Common Stock

14.36 USD
+0.11 (+0.77%)
Last: 11/19/2025, 2:47:31 PM
Fundamental Rating

5

Overall FONR gets a fundamental rating of 5 out of 10. We evaluated FONR against 188 industry peers in the Health Care Equipment & Supplies industry. FONR is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. FONR has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year FONR was profitable.
FONR had a positive operating cash flow in the past year.
FONR had positive earnings in each of the past 5 years.
In the past 5 years FONR always reported a positive cash flow from operatings.
FONR Yearly Net Income VS EBIT VS OCF VS FCFFONR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

1.2 Ratios

FONR has a better Return On Assets (3.60%) than 78.19% of its industry peers.
FONR's Return On Equity of 4.52% is fine compared to the rest of the industry. FONR outperforms 75.53% of its industry peers.
FONR has a better Return On Invested Capital (4.37%) than 74.47% of its industry peers.
FONR had an Average Return On Invested Capital over the past 3 years of 5.58%. This is below the industry average of 8.98%.
Industry RankSector Rank
ROA 3.6%
ROE 4.52%
ROIC 4.37%
ROA(3y)4.2%
ROA(5y)4.71%
ROE(3y)5.35%
ROE(5y)6.16%
ROIC(3y)5.58%
ROIC(5y)6.68%
FONR Yearly ROA, ROE, ROICFONR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

FONR has a Profit Margin of 7.48%. This is in the better half of the industry: FONR outperforms 77.66% of its industry peers.
FONR's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 11.11%, FONR is doing good in the industry, outperforming 78.19% of the companies in the same industry.
In the last couple of years the Operating Margin of FONR has declined.
With a Gross Margin value of 41.11%, FONR is not doing good in the industry: 64.89% of the companies in the same industry are doing better.
FONR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.11%
PM (TTM) 7.48%
GM 41.11%
OM growth 3Y-21%
OM growth 5Y-7.01%
PM growth 3Y-14.56%
PM growth 5Y-3.61%
GM growth 3Y-5.13%
GM growth 5Y-3.63%
FONR Yearly Profit, Operating, Gross MarginsFONR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FONR is destroying value.
FONR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for FONR has been reduced compared to 5 years ago.
Compared to 1 year ago, FONR has an improved debt to assets ratio.
FONR Yearly Shares OutstandingFONR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
FONR Yearly Total Debt VS Total AssetsFONR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

FONR has an Altman-Z score of 2.56. This is not the best score and indicates that FONR is in the grey zone with still only limited risk for bankruptcy at the moment.
FONR has a better Altman-Z score (2.56) than 68.09% of its industry peers.
The Debt to FCF ratio of FONR is 0.05, which is an excellent value as it means it would take FONR, only 0.05 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of FONR (0.05) is better than 94.15% of its industry peers.
FONR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, FONR is in the better half of the industry, outperforming 73.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Altman-Z 2.56
ROIC/WACC0.5
WACC8.73%
FONR Yearly LT Debt VS Equity VS FCFFONR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.3 Liquidity

FONR has a Current Ratio of 8.45. This indicates that FONR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 8.45, FONR belongs to the best of the industry, outperforming 91.49% of the companies in the same industry.
FONR has a Quick Ratio of 8.28. This indicates that FONR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 8.28, FONR belongs to the best of the industry, outperforming 91.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.45
Quick Ratio 8.28
FONR Yearly Current Assets VS Current LiabilitesFONR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

1

3. Growth

3.1 Past

The earnings per share for FONR have decreased strongly by -19.77% in the last year.
Measured over the past 5 years, FONR shows a small growth in Earnings Per Share. The EPS has been growing by 0.90% on average per year.
Looking at the last year, FONR shows a small growth in Revenue. The Revenue has grown by 1.42% in the last year.
FONR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.02% yearly.
EPS 1Y (TTM)-19.77%
EPS 3Y-11.06%
EPS 5Y0.9%
EPS Q2Q%-11.84%
Revenue 1Y (TTM)1.42%
Revenue growth 3Y2.25%
Revenue growth 5Y4.02%
Sales Q2Q%5.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FONR Yearly Revenue VS EstimatesFONR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.38 indicates a correct valuation of FONR.
Based on the Price/Earnings ratio, FONR is valued cheaply inside the industry as 88.83% of the companies are valued more expensively.
FONR is valuated cheaply when we compare the Price/Earnings ratio to 25.47, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.38
Fwd PE N/A
FONR Price Earnings VS Forward Price EarningsFONR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, FONR is valued cheaply inside the industry as 98.40% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, FONR is valued cheaply inside the industry as 93.62% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.17
EV/EBITDA 2.11
FONR Per share dataFONR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)13.74
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FONR!.
Industry RankSector Rank
Dividend Yield N/A

FONAR CORP

NASDAQ:FONR (11/19/2025, 2:47:31 PM)

14.36

+0.11 (+0.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-17 2025-11-17
Earnings (Next)02-16 2026-02-16
Inst Owners47.25%
Inst Owner Change-0.68%
Ins Owners5.07%
Ins Owner Change0%
Market Cap90.61M
Revenue(TTM)104.35M
Net Income(TTM)7.81M
Analysts0
Price TargetN/A
Short Float %0.43%
Short Ratio1.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.38
Fwd PE N/A
P/S 0.87
P/FCF 12.17
P/OCF 8.04
P/B 0.52
P/tB 0.55
EV/EBITDA 2.11
EPS(TTM)1.16
EY8.08%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.18
FCFY8.22%
OCF(TTM)1.79
OCFY12.43%
SpS16.54
BVpS27.35
TBVpS26.2
PEG (NY)N/A
PEG (5Y)13.74
Graham Number26.72
Profitability
Industry RankSector Rank
ROA 3.6%
ROE 4.52%
ROCE 5.81%
ROIC 4.37%
ROICexc 6.09%
ROICexgc 6.42%
OM 11.11%
PM (TTM) 7.48%
GM 41.11%
FCFM 7.14%
ROA(3y)4.2%
ROA(5y)4.71%
ROE(3y)5.35%
ROE(5y)6.16%
ROIC(3y)5.58%
ROIC(5y)6.68%
ROICexc(3y)7.78%
ROICexc(5y)9.2%
ROICexgc(3y)8.22%
ROICexgc(5y)9.77%
ROCE(3y)7.41%
ROCE(5y)8.87%
ROICexgc growth 3Y-21.28%
ROICexgc growth 5Y-6.2%
ROICexc growth 3Y-21.03%
ROICexc growth 5Y-5.92%
OM growth 3Y-21%
OM growth 5Y-7.01%
PM growth 3Y-14.56%
PM growth 5Y-3.61%
GM growth 3Y-5.13%
GM growth 5Y-3.63%
F-Score7
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Debt/EBITDA 0.01
Cap/Depr 81.24%
Cap/Sales 3.66%
Interest Coverage 453.04
Cash Conversion 69.13%
Profit Quality 95.41%
Current Ratio 8.45
Quick Ratio 8.28
Altman-Z 2.56
F-Score7
WACC8.73%
ROIC/WACC0.5
Cap/Depr(3y)64.91%
Cap/Depr(5y)77.48%
Cap/Sales(3y)2.95%
Cap/Sales(5y)3.54%
Profit Quality(3y)114.83%
Profit Quality(5y)119.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-19.77%
EPS 3Y-11.06%
EPS 5Y0.9%
EPS Q2Q%-11.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.42%
Revenue growth 3Y2.25%
Revenue growth 5Y4.02%
Sales Q2Q%5.14%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.86%
EBIT growth 3Y-19.22%
EBIT growth 5Y-3.28%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.88%
FCF growth 3Y-11.29%
FCF growth 5Y-10.21%
OCF growth 1Y-20.07%
OCF growth 3Y-9.7%
OCF growth 5Y-11.2%

FONAR CORP / FONR FAQ

Can you provide the ChartMill fundamental rating for FONAR CORP?

ChartMill assigns a fundamental rating of 5 / 10 to FONR.


Can you provide the valuation status for FONAR CORP?

ChartMill assigns a valuation rating of 4 / 10 to FONAR CORP (FONR). This can be considered as Fairly Valued.


Can you provide the profitability details for FONAR CORP?

FONAR CORP (FONR) has a profitability rating of 5 / 10.


How financially healthy is FONAR CORP?

The financial health rating of FONAR CORP (FONR) is 8 / 10.